This study investigates thromboembolic events in patients with metastatic or locally advanced pancreatic cancer. It looks at how an investigational medication might work for these patients.
The study evaluates the effectiveness of the investigational medication in preventing thromboembolic events. It focuses on understanding how safe and effective the medication is for patients.
- Who can participate: Adults 18 years and older with metastatic or locally advanced pancreatic cancer can participate if they are starting first-line chemotherapy, have a life expectancy of more than 4 months, and good organ function. Participants must also be willing to use contraception if of child-bearing potential.
- Study details: Participants will receive either the investigational medication or a placebo. They will continue their usual chemotherapy treatment during the study.
How understandable was the trial content above?
Hard to understand
Easy to understand